Cargando…
Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial
IMPORTANCE: It is unknown whether olanzapine combined with triplet antemetic therapy is effective for all patients undergoing highly emetogenic chemotherapy. A secondary analysis of randomized clinical trials using olanzapine may provide insight into the effectiveness of olanzapine for chemotherapy-...
Autores principales: | Abe, Masakazu, Yamaguchi, Takuhiro, Fujita, Yukiyoshi, Nishimura, Tomoyasu, Kitagawa, Koichi, Inui, Naoki, Hirano, Katsuya, Sakata, Yukio, Iihara, Hirotoshi, Shibuya, Yuichi, Suzuki, Kenichi, Shibata, Kazuhiko, Hori, Kensuke, Daga, Haruko, Nakayama, Toshiaki, Sakata, Yasuhiko, Takahashi, Takako Yanai, Zenda, Sadamoto, Hashimoto, Hironobu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155068/ https://www.ncbi.nlm.nih.gov/pubmed/37129897 http://dx.doi.org/10.1001/jamanetworkopen.2023.10894 |
Ejemplares similares
-
Study protocol for a double-blind, comparative, randomised Japanese trial of triplet standard antiemetic therapies with or without 5 mg olanzapine to prevent chemotherapy-induced nausea and vomiting for patients with breast cancer treated with an anthracycline/cyclophosphamide regimen (JTOP-B)
por: Ozeki, Rie, et al.
Publicado: (2022) -
Study protocol for an open-label, single-arm, multicentre phase II trial to evaluate the efficacy and safety of combined triplet therapy and olanzapine for prevention of carboplatin-induced nausea and vomiting in gynaecological cancer patients
por: Iihara, Hirotoshi, et al.
Publicado: (2019) -
Olanzapine: An Antiemetic Option for Chemotherapy-Induced Nausea and Vomiting
por: Brafford, Megan V., et al.
Publicado: (2014) -
The use of olanzapine as an antiemetic in palliative medicine: a systematic review of the literature
por: Saudemont, G., et al.
Publicado: (2020) -
Comparative evaluation of triplet antiemetic schedule versus doublet antiemetic schedule in chemotherapy-induced emesis in head and neck cancer patients
por: Kaushal, Pulkit, et al.
Publicado: (2015)